UPL stock edges up near 52-week high as India shares tread cautiously into year-end
29 December 2025
1 min read

UPL stock edges up near 52-week high as India shares tread cautiously into year-end

NEW YORK, December 29, 2025, 00:05 ET

  • UPL shares rose about 0.4% in early Mumbai trade, within roughly 1% of a 52-week high. 1
  • Indian benchmarks opened little changed as thin year-end volumes and foreign outflows kept risk appetite in check. 2
  • A Geojit strategist said the market may stay in a consolidation phase near term. 2

Shares of UPL rose in early trade on Monday, keeping the Indian agrochemicals maker close to its 52-week peak as investors stayed selective in thin year-end dealing. 1

The move matters because UPL has been one of the better-performing stocks in recent months, even as broader Indian equities have struggled to build momentum amid persistent foreign selling and muted liquidity. 1

Indian shares opened marginally higher, but gains were limited by concerns about foreign fund outflows and subdued year-end volumes, ETMarkets reported. 2

UPL was last traded at 777.40 rupees, up 0.44% from its previous close of 774.05 rupees, according to Economic Times data. 1

The stock had ended the prior session on Dec. 26 up 0.18% at 774.05 rupees, a liveblog on the Economic Times site showed. 3

UPL’s market value stood at about 65,789.82 crore rupees (about 658 billion rupees), with a trailing price-to-earnings ratio of about 30, Economic Times data showed. 1

The stock’s 52-week high is 786.30 rupees and its 52-week low is 493.00 rupees, according to the same data. 1

UPL is up about 18.8% over the past three months and about 54.9% over the past year, based on Economic Times returns data. 1

The Economic Times’ technical readout flagged a “weekly stochastic crossover” in the week ended Dec. 26 — a momentum signal traders use to spot shifts in buying pressure — and said similar signals have been followed by an average 8.32% gain within seven weeks over the past decade. 1

Analyst sentiment tracked by the Economic Times showed a “buy” consensus from 18 analysts, with targets ranging from 613 rupees at Centrum Broking to 880 rupees at JM Financial. 1

In India’s pesticides and agro-chemicals space, UPL competes with companies such as PI Industries, Bayer Cropscience and Rallis India, according to an Economic Times peers list. 4

“The consolidation phase is likely in the near-term,” said Dr. VK Vijayakumar, chief investment strategist at Geojit Investments, in an ETMarkets note on Monday’s market open. 2

Institutional flow data cited by ETMarkets showed foreign institutional investors were net sellers of a little over 317 crore rupees on Dec. 26, while domestic institutions were net buyers of 1,772 crore rupees. 2

UPL remained on traders’ radar after Economic Times said last week the stock broke out of a month-long consolidation and hit a fresh record high in December. 5

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Fitell stock pops after $0.10 dividend, loyalty payout plan puts record dates in focus
Previous Story

Fitell stock pops after $0.10 dividend, loyalty payout plan puts record dates in focus

Manappuram taps ex-RBL Bank CFO as group finance chief, okays Rs 250 crore for microfinance unit
Next Story

Manappuram taps ex-RBL Bank CFO as group finance chief, okays Rs 250 crore for microfinance unit

Go toTop